Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
17,471,639
-
Share change
-
-1,500,571
-
Total reported value
-
$13,056,000
-
Price per share
-
$0.75
-
Number of holders
-
36
-
Value change
-
-$3,982,355
-
Number of buys
-
10
-
Number of sells
-
31
Institutional Holders of ONCOMED PHARMACEUTICALS INC - COM (OMED) as of Q4 2018
As of 31 Dec 2018,
ONCOMED PHARMACEUTICALS INC - COM (OMED) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,471,639 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BVF INC/IL, HarbourVest Partners LLC, PERCEPTIVE ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, Candriam Luxembourg S.C.A., Vanguard Group Inc, CANNELL PETER B & CO INC, BlackRock Inc., and ACADIAN ASSET MANAGEMENT LLC.
This page lists
36
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.